Veracyte Announces In Vitro Diagnostic Agreement with Illumina to Broaden Availability of Its Tests for Patients Globally
07.11.2023 - Veracyte, Inc. (Nasdaq: VCYT) today announced that it has entered into a multi-year agreement with Illumina, Inc. (Nasdaq: ILMN) to develop and offer some of its high-performing molecular tests as decentralized in vitro diagnostic (IVD) tests on ... Seite 1
Marc Stapley Joydeep Goswami Veracyte Inc Illumina Inc Illumina Nextseq Prosigna Breast Cancer Assay
Source: wallstreet-online.de